Controlled Study to Evaluate the Efficacy and Safety of the Treatment With Growth Hormone in Tibia Fractures
Clinical trial NCT00254514 · COMPLETED
Trial details
- NCT number
- NCT00254514
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-08-01
- Primary completion
- 2003-10-01
- Enrollment
- 407
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.